(CYCCP)

Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
August 1, 2025$0.152025-07-212025-07-21
May 1, 2025$0.152025-04-292025-04-29
February 1, 2024$0.152024-01-192024-01-22
November 1, 2023$0.152023-10-192023-10-20
August 1, 2023$0.152023-07-202023-07-21

Dividends Summary

Company News

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
GlobeNewswire Inc. • Cyclacel Pharmaceuticals • August 4, 2025

Cyclacel Pharmaceuticals reported preclinical study findings demonstrating that biliary tract cancer cells are sensitive to plogosertib, a PLK1 inhibitor, with potential for targeted cancer treatment using BUBR1 as a biomarker.

Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Benzinga • Zacks • September 3, 2024

Cyclacel Pharmaceuticals (CYCC) has seen a downtrend recently, but a hammer chart pattern and strong agreement among analysts on earnings estimates suggest a potential trend reversal. The article recommends buying the stock now.